IXIGO — Le Travenues Technology Balance Sheet
0.000.00%
- IN₹129.34bn
- IN₹126.08bn
- IN₹9.14bn
Annual balance sheet for Le Travenues Technology, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 327 | 1,443 | 1,403 | 1,321 | 3,684 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 272 | 190 | 250 | 514 | 721 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 705 | 2,329 | 2,493 | 2,695 | 5,627 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 37.4 | 41.3 | 117 | 45.4 | 90 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,851 | 5,385 | 5,859 | 6,321 | 9,055 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,043 | 1,363 | 1,563 | 1,781 | 2,573 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,551 | 1,958 | 2,122 | 1,861 | 2,719 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 299 | 3,427 | 3,738 | 4,460 | 6,336 |
| Total Liabilities & Shareholders' Equity | 1,851 | 5,385 | 5,859 | 6,321 | 9,055 |
| Total Common Shares Outstanding |